Primary Hyperoxaluria Type 1 (PH1)

American Society of Nephrology (ASN) 2025

Congress Details

November 6-9, 2025

Houston, TX

The material below is provided to support scientific exchange and pertains to select congress resources. Any content about investigational therapeutics or investigational uses of locally approved products does not establish the safety or efficacy of these therapeutics or uses, and there is no guarantee of local regulatory approval.

All congress materials are copyrighted by Alnylam. Permission is required to copy or distribute.

For questions beyond a product’s authorized indications or for information not available here, please contact Alnylam Medical Information.

Congress Materials

ASN-2025-Final-60-Month-Efficacy,-Safety,-and-Kidney-Stone-Outcomes-of-a-Phase-3-Trial-of-Lumasiran-for-Primary-Hyperoxaluria-Type-1-in-Infants-and-Young-Children

Presentation Type

Poster

Location

Houston, TX

Title

Final 60-Month Efficacy, Safety, and Kidney Stone Outcomes of a Phase 3 Trial of Lumasiran for Primary Hyperoxaluria Type 1 in Infants and Young Children

ASN-2025-Long-term-Lumasiran-Treatment,-Kidney-Function,-and-Isolated-Kidney-Transplant-Outcomes-in-Primary-Hyperoxaluria-Type-1

Presentation Type

Poster

Location

Houston, TX

Title

Long-Term Lumasiran Treatment, Kidney Function, and Isolated Kidney Transplant Outcomes in Primary Hyperoxaluria Type 1

ASN-2025-Long-term-Lumasiran-Treatment,-Kidney-Function,-and-Isolated-Kidney-Transplant-Outcomes-in-Primary-Hyperoxaluria-Type-1

Presentation Type

Poster

Location

Houston, TX

Title

Impact of Lumasiran on Long-Term Clinical Outcomes in Primary Hyperoxaluria Type 1 (PH1): a Cohort Simulation Model

ASN-2025-Kidney-Survival-in-Patients-with-Primary-Hyperoxaluria-Type-1-Treated-with-Lumasiran-Compared-with-Historical-Controls

Presentation Type

Poster

Location

Houston, TX

Title

Kidney Survival in Patients with Primary Hyperoxaluria Type 1 Treated with Lumasiran Compared with Historical Controls

ASN-2025-Comparison-of-Patients-With-Primary-Hyperoxaluria-1-and-Late-Stage-Chronic-Kidney-Disease-From-BONAPH1DE-Registry-and-ILLUMINATE-C-Lumasiran-Trial

Presentation Type

Poster

Location

Houston, TX

Title

Comparison of Patients With Primary Hyperoxaluria 1 and Late-Stage Chronic Kidney Disease From BONAPH1DE Registry and ILLUMINATE-C Lumasiran Trial

Login and Sign up

Left Image

RNAiScience Data Hall is for healthcare professionals. By creating an account, you will have access to:

- All RNAi on-demand educational content
- Personalization experience with ability to bookmark content for future reference

First Name *

Last Name *

Enter your Institution Email *

Password *

Country *

Select Speciality *

Select Profession *

* Required Fields

By signing up you agree to Alnylam Terms of Conditions and Privacy Policy.